
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.720 | 3.170 | 0.450 |
Shares | 1.590 | 1.590 | 0.000 |
Bonds | 95.390 | 95.390 | 0.000 |
Preferred | 0.100 | 0.100 | 0.000 |
Other | 0.200 | 0.200 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.603 | 11.521 |
Price to Book | 1.304 | 1.082 |
Price to Sales | 2.073 | 1.167 |
Price to Cash Flow | 6.272 | 5.434 |
Dividend Yield | 2.701 | 2.315 |
5 Years Earnings Growth | 18.184 | 18.184 |
Name | Net % | Category Average |
---|---|---|
Energy | 89.420 | 82.884 |
Consumer Cyclical | 6.280 | 6.280 |
Communication Services | 4.300 | 4.516 |
Number of long holdings: 514
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BASS PRO TERM B 1LN 01/23/32 | - | 2.62 | - | - | |
GOLDEN NUGGET TM 1LN 1/27/29 | - | 1.54 | - | - | |
SFR TERM B14 1LN 08/15/28 | XAF6628DAN49 | 1.20 | - | - | |
SOLERA TERM B 1LN 6/2/28 | - | 1.04 | - | - | |
Acrisure Term B6 1ln 11/06/30 | - | 1.01 | - | - | |
Asurion Tm B12 1ln 09/19/30 | - | 0.93 | - | - | |
NOVOLEX TERM 1LN 04/13/29 | - | 0.83 | - | - | |
MEDLINE TERM 1LN 10/21/2028 | - | 0.81 | - | - | |
UKG TERM B 1LN 02/10/31 | - | 0.79 | - | - | |
CSC SERVICEWORKS TM B 1LN 2/28 | - | 0.79 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Bal Income Priv Pool F | 4.05B | 6.14 | 9.92 | 5.35 | ||
Fidelity Bal Income Priv Pool F5 | 4.05B | 6.15 | 9.94 | 5.36 | ||
Fidelity Bal Incm Prv Pool Cl S8 | 4.05B | 5.37 | 8.72 | 4.19 | ||
Fidelity Bal Incm Prv Pool Cl S5 | 4.05B | 5.37 | 8.72 | 4.19 | ||
Fidelity Bal Incm Prv Pool Cl B | 4.05B | 5.36 | 8.70 | 4.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review